实用医学杂志 ›› 2025, Vol. 41 ›› Issue (21): 3311-3314.doi: 10.3969/j.issn.1006-5725.2025.21.002

• 述评 • 上一篇    

中国动脉粥样硬化性心血管疾病危险因素管理现状与防控策略:基于《中国心血管健康与疾病报告2024》

梁玮昊,刘晨,董吁钢()   

  1. 中山大学附属第一医院心血管内科 (广东 广州 510080 )
  • 收稿日期:2025-07-24 出版日期:2025-11-10 发布日期:2025-11-13
  • 通讯作者: 董吁钢 E-mail:dongxg@mail.sysu.edu.cn
  • 作者简介:董吁钢,中山大学附属第一医院心血管内科学科带头人,教授,主任医师,国务院特殊津贴专家;中国生物医学工程学会体外反搏分会主任委员;中国老年医学学会心电与心功能分会副会长;中国疾控中心慢病中心心衰全程管理专家委员会副主任委员;中国心衰联盟中心执行主席;广东省医师协会心力衰竭医师分会副主任委员;中华医学会心血管病分会前任委员兼心力衰竭学组和代谢学组副组长;中国医师协会心血管内科医师分会前任常委兼心力衰竭学组副组长;广东省医师协会心内科医师分会名誉主任委员。安装了广东省第1例(全国第2例)三腔自动复律除颤(抗心力衰竭)起搏器,率先在广东省开展了起搏器治疗阵发性心房纤颤的工作;2002年获吴阶平医学研究奖三等奖;2005年获广东省科学技术二等奖。

China cardiovascular health and disease report 2024: Managing cardiovascular risk factors remains a challenging task

Weihao LIANG,Chen LIU,Yugang. DONG()   

  1. Department of Cardiology,the First Affiliated Hospital of Sun Yat?sen University,Guangzhou 510080,Guangdong,China
  • Received:2025-07-24 Online:2025-11-10 Published:2025-11-13
  • Contact: Yugang. DONG E-mail:dongxg@mail.sysu.edu.cn

摘要:

《中国心血管健康与疾病报告2024》近期发布,报告中全面、详细地展示了我国目前心血管疾病及其相关危险因素的现状。报告显示,我国心血管疾病(CVD)的发病数、发病率、标化发病率持续呈上升趋势,其中动脉粥样硬化性心血管疾病(ASCVD)是构成CVD死亡负担的重要原因。ASCVD可防可控,但报告中显示ASCVD的关键危险因素(吸烟、肥胖、高血压、血脂异常、糖尿病等)的控制水平仍有待改善。本文旨在系统总结针对ASCVD各关键危险因素的流行、管理现状与防控建议,希望借此提醒临床医生不仅要治疗ASCVD,更要指导患者防治ASCVD的关键危险因素,以期降低ASCVD的患病率和死亡率。

关键词: 动脉粥样硬化性心血管疾病, 危险因素, 疾病预防

Abstract:

The China Cardiovascular Health and Disease Report 2024 has recently been released, offering a comprehensive and detailed assessment of the current status of cardiovascular diseases (CVD) and their associated risk factors in China. The report reveals that the number of CVD cases, as well as the overall and age-standardized incidence rates, continue to increase. Among these conditions, atherosclerotic cardiovascular disease (ASCVD) constitutes a major contributor to CVD-related mortality. Although ASCVD is largely preventable and controllable, the management of key modifiable risk factors?such as smoking, obesity, hypertension, dyslipidemia, and diabetes?remains suboptimal. This article systematically summarizes the prevalence, current management practices, and evidence-based prevention strategies for each major ASCVD risk factor, aiming to reinforce for clinicians the importance of not only treating established ASCVD but also proactively guiding patients in the prevention and control of its underlying risk factors, thereby reducing the overall burden of ASCVD in terms of both prevalence and mortality.

Key words: atherosclerotic cardiovascular disease, risk factor, disease prevention

中图分类号: